Gene · 28874
Papers2,209
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,209
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crystal structure of a family VIII β-lactamase fold hydrolase reveals the molecular mechanism for its broad substrate scope. | FEBS J | 2022 | 35694902 | PubTator, text mining | PubMed |
| Evaluation of Financial Subsidy for Agriculture Based on Combined Algorithm. | Comput Intell Neurosci | 2022 | 35694608 | PubTator, text mining | PubMed |
| Comparison of Conventional and Nonconventional Hydrogen Bond Donors in Au- Complexes. | J Phys Chem A | 2022 | 35687835 | PubTator, text mining | PubMed |
| Sustainable supplier selection using HF-DEA-FOCUM-MABAC technique: a case study in the Auto-making industry. | Soft comput | 2022 | 35677555 | PubTator, text mining | PubMed |
| Trends and Disparities in Adult Body Mass Index Across the 47 Prefectures of Japan, 1975-2018: A Bayesian Spatiotemporal Analysis of National Household Surveys. | Front Public Health | 2022 | 35669745 | PubTator, text mining | PubMed |
| Using the FITradeoff Decision Support System to Support a Brazilian Compliance Organization Program. | Inf Syst Front | 2022 | 35669334 | PubTator, text mining | PubMed |
| Aberrant Fucosylation of Saliva Glycoprotein Defining Lung Adenocarcinomas Malignancy. | ACS Omega | 2022 | 35664632 | PubTator, text mining | PubMed |
| Lens Fibrosis: Understanding the Dynamics of Cell Adhesion Signaling in Lens Epithelial-Mesenchymal Transition. | Front Cell Dev Biol | 2022 | 35656546 | PubTator, text mining | PubMed |
| Graft versus host disease after liver transplantation following radiotherapy for the treatment of hepatocellular carcinoma: A case report and literature review. | SAGE Open Med Case Rep | 2022 | 35646373 | PubTator, text mining | PubMed |
| Analyzing the ecological relations of technology innovation of the Chinese high-tech industry based on the Lotka-Volterra model. | PLoS One | 2022 | 35639686 | PubTator, text mining | PubMed |
| Application Research for Fusion Model of Pseudolabel and Cross Network. | Comput Intell Neurosci | 2022 | 35634050 | PubTator, text mining | PubMed |
| Structural characterization of fungus-specific histone deacetylase Hos3 provides insights into developing selective inhibitors with antifungal activity. | J Biol Chem | 2022 | 35623387 | PubTator, text mining | PubMed |
| The evolutionary dynamics and epidemiological history of hepatitis C virus genotype 6, including unique strains from the Li community of Hainan Island, China. | Virus Evol | 2022 | 35600095 | PubTator, text mining | PubMed |
| Differences in interaction lead to the formation of different types of insulin amyloid. | Sci Rep | 2022 | 35595809 | PubTator, text mining | PubMed |
| Folic acid intervention during pregnancy alters DNA methylation, affecting neural target genes through two distinct mechanisms. | Clin Epigenetics | 2022 | 35578268 | PubTator, text mining | PubMed |
| Actual Associations between HLA Haplotype and Graves' Disease Development. | J Clin Med | 2022 | 35566618 | PubTator, text mining | PubMed |
| Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. | Int J Mol Sci | 2022 | 35563414 | PubTator, text mining | PubMed |
| Conserved structural elements specialize ATAD1 as a membrane protein extraction machine. | Elife | 2022 | 35550246 | PubTator, text mining | PubMed |
| Improved outcomes of single-unit cord blood transplantation for acute myeloid leukemia by killer immunoglobulin-like receptor 2DL1-ligand mismatch. | Bone Marrow Transplant | 2022 | 35538140 | PubTator, text mining | PubMed |
| Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4. | J Med Chem | 2022 | 35522528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28874/papers?page=16